Serum paraoxonase activity and oxidative DNA damage in patients with laryngeal squamous cell carcinoma

Journal of Craniofacial Surgery

Volumn 21, Issue 6, 2010, Pages 1745-1749

  Karaman, Emin ^a   Uzun, Hafize ^a   Papila, Irfan ^a   Balci, Huriye ^a   Ozdilek, Alper ^a   Genc, Habibe ^a   Yanardag, Halil ^a   Papila, Cigdem ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

8 hydroxy 2 deoxyguanosine; Laryngeal squamous cell carcinoma; oxidative DNA damage; oxidative stress; paraoxonase

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; ARYLDIALKYLPHOSPHATASE; DEOXYGUANOSINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PON1 PROTEIN, HUMAN; SCAVENGER; SERUM ALBUMIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AGED; BLOOD; CANCER STAGING; CASE CONTROL STUDY; COLORIMETRY; COMPARATIVE STUDY; CONFERENCE PAPER; DNA DAMAGE; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; LARYNX TUMOR; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHYSIOLOGY; SMOKING; SPECTROPHOTOMETRY; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ARYLDIALKYLPHOSPHATASE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; COLORIMETRY; DEOXYGUANOSINE; DNA DAMAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREE RADICAL SCAVENGERS; HUMANS; INDICATORS AND REAGENTS; LARYNGEAL NEOPLASMS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NEOPLASM STAGING; OXIDATIVE STRESS; SERUM ALBUMIN; SMOKING; SPECTROPHOTOMETRY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 78650568947     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181f4040a     Document Type: Conference Paper

References (21)

1. Singh NP, Verma KB. Case report of a laryngeal squamous cell carcinoma treated with artesunate. Arch Oncol 2002;10:279-280
2. Choong N, Vokes E. Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin 2008;58:32-53
3. Valko M, Rhodes CJ, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40
4. Munnia A, Amasio ME, Peluso M. Exocyclic malondialdehyde and aromatic DNA adducts in larynx tissues. Free Radic Biol Med 2004;37:850-858
5. Kandpal N, Shukla GK, Bhatia N, et al. Oxidant, vitamin A and angiogenic markers in laryngeal cancer patients. J Laryngol Otol 2003;117:871-874
6. Davies HG, Richter RJ, Keifer M, et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996;14:334-336
7. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-310
8. Hasselwander O, Savage DA, McMaster D, et al. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kidney Int 1999;56:289-298
9. Seven A, Civelek S, Inci E, et al. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem 1999;32:369-373
10. Bergman V, Leanderson P, Starkhammar H, et al. Urinary excretion of 8-hydroxydeoxyguanosine and malondialdehyde after high dose radiochemotherapy preceding stem cell transplantation. Free Radic Biol Med 2004;36:300-306
11. Caliskan-Can E, Firat H, Ardi S, et al. Increased levels of 8-hydroxydeoxyguanosine and its relationship with lipid peroxidation and antioxidant vitamins in lung cancer. Clin Chem Lab Med 2008;46:107-112
12. Yigitbasi OG, Guney E, Haghighi N, et al. Oxidant and antioxidant status in larynx squamous cell carcinomas. J Exp Clin Cancer Res 2000;19:447-451
13. Elkiran ET, Mar N, Aygen B, et al. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 2007;7:48
14. Koch WM, Lango M, Sewell D, et al. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999;109:1544-1551
15. James RW, Leviev I, Righetti A. Smoking is associated with reduced paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000;101:2252-2257
16. Loft S, Vistisen K, Ewertz M, et al. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992;13: 2241-2247
17. Räsänen JV, Sihvo EI, Ahotupa MO, et al. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours. Eur J Surg Oncol 2007;33:1164-1168
18. Cooke MS, Evans MD, Dizdaroglu M, et al. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003;17:1195-1214 (Pubitemid 36775767)
19. Bentz B. Head and neck squamous cell carcinoma as a model of oxidative-stress and cancer. J Surg Oncol 2007;96:190-191
20. Younes M, Lechago J, Chakraborty S, et al. Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasia. Scand J Gastroenterol 2000;35:131-137
21. Carlson N, Lechago J, Richter J, et al. Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation. Am J Gastroenterol 2002;97:1340-1345